Bioanalytical Systems, Inc. (NASDAQ:BASI)

Tuesday, December 24, 2013 | Web News
Fourth Quarter Fiscal 2013 Results For the three months ended September 30, 2013, revenue decreased to $5,508,000 compared to $6,540,...
Friday, October 18, 2013 | Web News
Third Quarter 2013 Results For the three months ended June 30, 2013, revenue decreased to $5,600,000 compared to $7,186,000...
Saturday, July 31, 2010 | Web News
On February 7, 2011, we initiated a short-term trading position in shares of BASI @ $2.70. The company posted strong fiscal...
See All Research...
BASi is a pharmaceutical development company providing contract research services and monitoring instruments to the world’s leading drug development companies and medical research organizations. The company focuses on developing innovative services and products that increase efficiency and reduce the cost of taking a new drug to market. Visit www.BASInc.com for more about BASi.

Web site: http://www.bioanalytical.com

Last updated February 7, 2011